Total Payments
$4,295
2024 Payments
$852.18
Companies
16
Transactions
81
Medicare Patients
2,280
Medicare Billing
$227,763
Payment Breakdown by Category
Food & Beverage$2,570 (59.8%)
Travel$1,725 (40.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,570 | 78 | 59.8% |
| Travel and Lodging | $1,725 | 3 | 40.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Penumbra, Inc. | $2,030 | 4 | $0 (2022) |
| GlaxoSmithKline, LLC. | $781.24 | 30 | $0 (2024) |
| GENZYME CORPORATION | $382.16 | 10 | $0 (2024) |
| Mylan Specialty L.P. | $189.56 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $173.93 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $160.72 | 8 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $123.76 | 1 | $0 (2024) |
| Genentech USA, Inc. | $108.80 | 1 | $0 (2019) |
| Insmed, Inc. | $95.98 | 1 | $0 (2021) |
| Grifols USA, LLC | $80.70 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $852.18 | 35 | GlaxoSmithKline, LLC. ($223.46) |
| 2023 | $479.64 | 22 | GlaxoSmithKline, LLC. ($247.42) |
| 2022 | $2,415 | 18 | Penumbra, Inc. ($2,030) |
| 2021 | $237.76 | 3 | Insmed, Inc. ($95.98) |
| 2020 | $202.01 | 2 | GlaxoSmithKline, LLC. ($202.01) |
| 2019 | $108.80 | 1 | Genentech USA, Inc. ($108.80) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $14.35 | General |
| Category: Medical Device | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.16 | General |
| Category: Immunology | ||||||
| 10/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: Immunology | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.03 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $123.76 | General |
| Category: SURGERY | ||||||
| 08/13/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.57 | General |
| Category: Immunology | ||||||
| 07/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,010 | 1,269 | $238,953 | $97,789 |
| 2022 | 16 | 946 | 1,191 | $232,708 | $93,388 |
| 2021 | 13 | 324 | 446 | $79,295 | $36,586 |
Total Patients
2,280
Total Services
2,906
Medicare Billing
$227,763
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 73 | 161 | $77,924 | $27,037 | 34.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 87 | 144 | $24,768 | $13,103 | 52.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 165 | $23,100 | $10,393 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 102 | $21,012 | $9,759 | 46.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 80 | 82 | $18,778 | $8,083 | 43.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 80 | 114 | $13,680 | $6,951 | 50.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $14,352 | $6,554 | 45.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 49 | 50 | $16,800 | $6,294 | 37.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 37 | 37 | $3,922 | $2,661 | 67.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 86 | 94 | $6,774 | $1,570 | 23.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 34 | $2,482 | $1,456 | 58.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 74 | 74 | $5,375 | $1,139 | 21.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $1,638 | $1,131 | 69.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 54 | 54 | $3,402 | $473.79 | 13.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 42 | 42 | $3,337 | $420.30 | 12.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 13 | 13 | $1,105 | $415.87 | 37.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $504.00 | $347.88 | 69.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 139 | 267 | $45,924 | $21,714 | 47.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 68 | 120 | $58,080 | $20,812 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 166 | $23,240 | $10,768 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 89 | $18,334 | $8,333 | 45.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 52 | 52 | $17,472 | $8,058 | 46.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $15,732 | $7,013 | 44.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 46 | 46 | $10,534 | $4,934 | 46.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 57 | $6,840 | $3,217 | 47.0% |
About Dr. Ria Itty, M.D
Dr. Ria Itty, M.D is a Pulmonary Disease healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2015. The National Provider Identifier (NPI) number assigned to this provider is 1770967275.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ria Itty, M.D has received a total of $4,295 in payments from pharmaceutical and medical device companies, with $852.18 received in 2024. These payments were reported across 81 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,570).
As a Medicare-enrolled provider, Itty has provided services to 2,280 Medicare beneficiaries, totaling 2,906 services with total Medicare billing of $227,763. Data is available for 3 years (2021–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Lafayette, LA
- Active Since 07/14/2015
- Last Updated 07/27/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1770967275
Products in Payments
- Indigo System (Device) $2,030
- DUPIXENT (Biological) $556.09
- TRELEGY ELLIPTA (Drug) $391.54
- NUCALA (Biological) $274.34
- Da Vinci Surgical System (Device) $123.76
- YUPELRI (Drug) $123.65
- ANORO ELLIPTA (Drug) $115.36
- Esbriet (Biological) $108.80
- Arikayce (Drug) $95.98
- OFEV (Drug) $89.32
- Prolastin-C Liquid (Biological) $80.70
- STIOLTO RESPIMAT (Drug) $71.40
- Yupelri (Drug) $65.91
- BASE UNIT SERVO-U (Device) $51.00
- TEZSPIRE (Biological) $43.42
- Impella (Device) $28.02
- TYVASO (Drug) $18.27
- (AK6) Vest Therapy (Device) $14.35
- GIAPREZA (Drug) $13.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Lafayette
Mr. Walter Brown, Md, MD
Pulmonary Disease — Payments: $12,452
Pulmonary Disease $12,452
Mr. George Guidry, Md, MD
Pulmonary Disease — Payments: $11,149
Pulmonary Disease $11,149
Timothy Keys, M.d, M.D
Pulmonary Disease — Payments: $10,588
Pulmonary Disease $10,588
Fadi Malek, M.d. F.c.c.p, M.D. F.C.C.P
Pulmonary Disease — Payments: $9,325
Pulmonary Disease $9,325
Justin Ardoin, M.d, M.D
Pulmonary Disease — Payments: $8,447
Pulmonary Disease $8,447
Richard Fei, M.d. F.c.c.p, M.D. F.C.C.P
Pulmonary Disease — Payments: $5,969
Pulmonary Disease $5,969